MedTrace Logo

AECOPD and Nutritional Supplementation in COPD

NCT06801964 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2025-01-30

No results posted yet for this study

Summary

Better understanding of the duration needed to overcome metabolic disturbances in patients experiencing exacerbation. Also, the explore role of nutritional intervention in the treatment program of stable COPD patients and in those recovering from an acute exacerbation (AECOPD) is important to restore loss of muscle mass and function and to reduce readmission and hospitalization rate of these patients, thereby leading to improved clinical and overall outcome as well as reduction of health care costs.

Conditions

  • Obstructive Pulmonary Disease
  • Exacerbation Copd

Interventions

OTHER

Stable isotope infusion

such as glycerol, D2O, tyrosine, phenylalanine, glucose, arginine, and citrulline

DIETARY_SUPPLEMENT

Protein and Fish Oil

milk/carbohydrate mixture and supplementation of 3.5g of EPA+DHA (7g of fish oil)

DIETARY_SUPPLEMENT

Protein and Olive Oil

milk/carbohydrate mixture with olive oil

DIETARY_SUPPLEMENT

Carbohydrate and Olive Oil

carbohydrate mixture with olive oil

Sponsors & Collaborators

Principal Investigators

  • Marielle Engelen · Texas A&M University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-20
Primary Completion
2019-01-08
Completion
2019-01-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06801964 on ClinicalTrials.gov